001     52117
005     20180211182323.0
024 7 _ |2 DOI
|a 10.1055/s-2006-926315
024 7 _ |2 WOS
|a WOS:000235670600001
037 _ _ |a PreJuSER-52117
041 _ _ |a eng
082 _ _ |a 540
084 _ _ |2 WoS
|a Chemistry, Organic
100 1 _ |a Bode, S.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB12652
245 _ _ |a Stereoselective Synthesis of 1,3-diols
260 _ _ |a Stuttgart [u.a.]
|b Thieme
|c 2006
300 _ _ |a 557 - 588
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Synthesis: Journal of Synthetic Organic Chemistry
|x 0039-7881
|0 5695
|y 4
|v
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Many polyketide-derived natural products contain a synor anti-1,3-diol unit. No general and simple approach exists for the flexible synthesis of polyols and other polyketide-derived structural units, therefore a multitude of methods for the stereoselective synthesis of 1,3-diols has been developed. Asymmetric homogeneous and heterogeneous hydrogenation and diastereoselective reduction, chain elongation, enzymatic and nonenzymatic desymmetrization, or dynamic kinetic resolution are some of these methods. The development of different methods to synthesize these 1,3-diols stereoselectively is important, as often small structural changes in a molecule result in low yields or low stereoselectivity with a known method. This review article highlights some of the recent developments in this field.
536 _ _ |a Biotechnologie
|c PBT
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK410
|x 0
588 _ _ |a Dataset connected to Web of Science
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a asymmetric synthesis
653 2 0 |2 Author
|a reductions
653 2 0 |2 Author
|a aldol reactions
653 2 0 |2 Author
|a biocatalysis
653 2 0 |2 Author
|a desymmetrizations
653 2 0 |2 Author
|a alcohols
700 1 _ |a Wolberg, M.
|b 1
|u FZJ
|0 P:(DE-Juel1)VDB1800
700 1 _ |a Müller, M.
|b 2
|u FZJ
|0 P:(DE-Juel1)VDB1106
773 _ _ |a 10.1055/s-2006-926315
|g p. 557 - 588
|p 557 - 588
|q 557 - 588
|0 PERI:(DE-600)2033062-5
|t Synthesis
|y 2006
|x 0039-7881
856 7 _ |u http://dx.doi.org/10.1055/s-2006-926315
909 C O |o oai:juser.fz-juelich.de:52117
|p VDB
913 1 _ |k PBT
|v Biotechnologie
|l ohne FE
|b außerhalb PoF
|0 G:(DE-Juel1)FUEK410
|x 0
914 1 _ |y 2006
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k IBT-2
|l Biotechnologie 2
|g IBT
|z ab 31.10.10 weitergeführt IBG-1
|0 I:(DE-Juel1)VDB56
|x 0
970 _ _ |a VDB:(DE-Juel1)81854
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBG-1-20101118


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21